Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Male hypogonadotropic hypogonadism

R W Whitcomb1, W F Crowley

  • 1Department of Medicine, Massachusetts General Hospital, Boston.

Endocrinology and Metabolism Clinics of North America
|March 1, 1993
PubMed
Summary

Male hypogonadotropic hypogonadism stems from issues with gonadotropin-releasing hormone or pituitary hormone secretion. Accurate diagnosis and treatment are crucial for affected individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional consequences of AXL sequence variants in hypogonadotropic hypogonadism.

The Journal of clinical endocrinology and metabolism·2014
Same author

Translational careers.

Science (New York, N.Y.)·2009
Same author

CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.

Clinical genetics·2008
Same author

Kisspeptin and GPR54: discovery of a novel pathway in reproduction.

Journal of neuroendocrinology·2008
Same author

Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.

The Journal of clinical endocrinology and metabolism·2006
Same author

Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.

The Journal of clinical endocrinology and metabolism·2006

Area of Science:

  • Endocrinology
  • Reproductive Medicine
  • Male Reproductive Health

Background:

  • Hypogonadotropic hypogonadism (HH) in males results from impaired gonadotropin-releasing hormone (GnRH) secretion or pituitary dysfunction affecting luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release.
  • Emerging research in animal and human models offers insights into the pathophysiology of GnRH-deficient states.
  • Distinguishing between a variant of normal and true HH is clinically significant.

Purpose of the Study:

  • To review the causes and diagnostic approaches for male hypogonadotropic hypogonadism.
  • To highlight recent advancements in diagnostic techniques for GnRH deficiency.
  • To discuss the impact of new hormonal treatments on patient outcomes.

Main Methods:

  • Review of recent scientific literature on male hypogonadotropic hypogonadism.
  • Analysis of pathophysiologic mechanisms underlying GnRH deficiency.
  • Evaluation of current diagnostic and therapeutic strategies.

Main Results:

  • Identified alterations in GnRH secretion and pituitary hormone production as key causes of male HH.
  • Highlighted the importance of differentiating true HH from normal variants.
  • Noted advancements in diagnostic tools and hormonal therapies.

Conclusions:

  • Understanding the underlying causes of male hypogonadotropic hypogonadism is essential for accurate diagnosis.
  • Recent developments in diagnostics and treatment offer improved prospects for managing male HH.
  • Further research into GnRH-deficient states can refine clinical management and patient outcomes.

Related Experiment Videos